Understanding the costs of drug-related actions is an important aspect of drug policy. Some of the funds allocated by governments to expenditure on tasks related to drugs are identified as such in the budget (‘labelled’). Often, however, the majority of drug-related expenditure is not identified (‘unlabelled’) and must be estimated using modelling approaches.
The available information does not allow reporting on the size and trends of drug-related public expenditures in Austria.
However, in 2013, a study on the cost of drug dependency estimated that the use of illicit drugs results in an annual cost totalling EUR 278 million. This cost comprised healthcare expenditure (EUR 135 million), social expenditure (EUR 51 million) and state expenditure (for police and court activities) (EUR 96 million)
Public expenditure related to illicit drugs in Austria
NB Based on estimates of Austria’s labelled and unlabelled public expenditure in 2013.